论文信息 - A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium - 字舞流文

A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium

E. Eisenhauer | S. Baruchel | M. Bernstein | D. Wall | Y. Samson | Darcy Nicksy | N. Wainman | S. Desai | Alexandra P. Zorzi